Preferred orientation in an angled intercalation site of a chloro-substituted lambda- [Ru(TAP)2(dppz)]2+ complex bound to d(TCGGCGCCGA)2 by Hall, James et al.
1 
 
Preferred orientation in an angled intercalation site of a chloro-substituted lambda- 
[Ru(TAP)2(dppz)]
2+
 complex bound to d(TCGGCGCCGA)2 
 
James P. Hall, Hanna Beer, Katrin Buchner, David J. Cardin and Christine J. Cardin 
 
Chemistry Department, University of Reading, Whiteknights, Reading, RG6 6AD, 
United Kingdom 
 
The crystal structure of the ruthenium DNA ‘light-switch’ complex -
[Ru(TAP)2(11-Cl-dppz)]
2+ 
(TAP = tetraazaphenanthrene, dppz = dipyrido[3,2-
a':2',3'-c]phenazine)) bound to the oligonucleotide duplex d(TCGGCGCCGA)2 is 
reported. The synthesis of the racemic ruthenium complex is described for the first 
time, and the racemate was used in this study.  The crystal structure, at atomic 
resolution (1.0 Å), shows one ligand as a wedge in the minor groove, resulting in the 
51 kinking of the double helix, as with the parent lambda-[Ru(TAP)2(dppz)]
2+
.
 
Each 
complex binds to one duplex by intercalation of the dppz ligand and also by semi-
intercalation of  one of the orthogonal TAP ligands into a second symmetrically 
equivalent duplex. The 11-Cl substituent binds with the major component (66%) 
oriented with the  11-chloro substituent on the purine side of the terminal step of the 
duplex.  
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Introduction 
 
In the attempt to improve the photophysical and therapeutic potential of polypyridyl 
ruthenium complexes, a large number of derivatives have been synthesized and their 
solution properties studied. The photophysical behaviour has been comprehensively 
reviewed [1], but much less is known about the precise DNA binding modes of this 
family of complexes. The ‘light-switch’ complexes such as [Ru(phen)2dppz]
2+
 and 
[Ru(bpy)2(dppz)]
2+
 have been particularly intensively studied in solution, and were 
finally were shown to crystallize with DNA decamer duplexes[2,3]. Although we were 
unable to crystallize Λ-Ru(phen)2(dppz)]
2+
 with the sequence d(TCGGCGCCGA), we 
were able to grow crystals with this sequence containing Λ-[Ru(TAP)2(dppz)]
2+
, showing 
both intercalation and semi-intercalation [4], the same sequence as is presented in this 
study. In these studies we have used the tetraaza (TAP) analogue instead of the 
phenanthroline (phen), which contains two additional ring N atoms and hence has 
different luminescence and hydrogen bonding properties. The differences between TAP 
and phen ligands in solution are due to the very different electronic effects, which make 
the TAP complexes photo-oxidizing [5]. They are isosteric ligands, but the TAP is much 
more hydrophilic, which is probably more relevant than its photooxidising properties 
when studying crystallogenesis. The group of DNA sequences chosen were originally 
chosen for study because of their interest as Holliday junction forming sequences [6], and 
it is still not clear whether the more complex solution equilibria associated with this 
group of sequences has any bearing on the success of our recent crystallisation studies.  
Our interest in studying asymmetrically substituted dppz ligands came from our earlier 
observations that symmetry was lowered by angled intercalation, such that only one face 
of the dppz ligand was in contact with aqueous solution; the other was protected from 
water by the DNA backbone. The current theory of the ‘light-switch’ effect postulates 
that the increased luminescence lifetime of the excited state is due to the protection of the 
dppz phenazine N from interaction with solvent water [7]. We were therefore interested 
to see how asymmetric halogen substitution would modify the angled intercalation 
geometry, and whether there would be a site preference in an angled geometry.  
Therefore we here report the atomic resolution structure of -[Ru(TAP)2(11-Cl-dppz]
2+
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(Figure 1a) crystallised with the d(TCGGCGCCGA) DNA duplex, which adopts the 
overall conformation shown in Figure 1b in the crystal lattice.  
 
 
 
Figure 1  | Assembly of the crystal structure.  
 
Results and discussion 
The title compound is novel. It was obtained by condensation of 4-chloro-ortho-
phenylene diamine with [Ru(TAP)2pd]
2+
, where pd is phenanthroline-5,6-dione. 
Orange-red rhombohedral crystals were obtained in the presence of barium ions after a 
few days, and diffracted to atomic resolution, as previously observed for the parent 
compound.  As in our previous work [2,4] the ruthenium-containing solution used for the 
crystallisation experiments was a racemic mixture of the chloride salt. Structural analysis 
revealed that only the -enantiomer had bound, giving a structure with asymmetric unit 
consisting of a single ruthenium cation (Figure 1a), a single strand of 
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d(TCGGCGCCGA), in the conformation shown in Figure 1b, a barium cation, and 92 
water molecules. The final resolution of the data was 1.02 Å, and the final conventional 
R-factor 10.3%, meaning that the structure is known with an almost ‘small molecule’ 
degree of precision. At this resolution alternative conformations will be clearly 
observable and can be accurately modelled. The parent structure was determined with 
comparable precision and resolution, being in the top 1% for precision of structures 
deposited in the PDB, but was remarkable in showing no sign of conformational disorder, 
and was accompanied by a high degree of water ordering. The introduction of 
asymmetry, giving a major and a minor Cl position, also generates disorder of one strand 
of the phosphate backbone, notably at the phosphate groups on either side of the 
intercalation cavity (the A10 residue). The second orientation of the ruthenium complex is 
almost exactly superimposable, except for the Cl location, and is refined at 33% 
statistical occupancy.   
The full data collection and  refinement statistics are shown in Table 1. 
 
 
 
Data Collection   
Space group P 43212 
Cell Dimensions (Å) a=b= 42.330, c = 39.630 
Resolution (Å) 28.93-1.02 (1.05-1.02)* 
Rmerge 0.028(0.592) 
I/σI 24.7(2.8) 
Completeness (%) 98.5(99.5) 
Multiplicity 6.1(6.0) 
*Outer shell statistics are shown in parenthesis 
Refinement   
No. Reflections 17529 
Rwork/Rfree 0.10/0.11 
No. Atoms 
 DNA 381 
Ligands 147 
Water 81 
Average B 
Factors 
 DNA 17.23 
Ligands 14.64 
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Water 29.09 
rmsd 
 Bond lengths, 
(Å) 0.014 
Bond Angles (°) 2.34 
PDB ID 4III 
 
The structure obtained has the gross features previously observed in the structure of -
[Ru(TAP)2dppz]
2+
 with the d(TCGGCGCCGA) sequence, with which the present 
structure is isostructural,  The ruthenium complex links two duplexes, with one TAP 
moiety semi-intercalated at the G3-G4/C6-C7
 
step, and the 11-chloro-dppz intercalated at 
the G9-A10 /T1-C2 step.  The A10 base is flipped out, forming a reverse Watson-Crick 
basepair with a symmetry related thymine base. The flipping out created an open side to 
the intercalation cavity, on the purine side, and it is on this side that most of the electron 
density of the Cl substituent is observed. Figure 1c shows an assembly of four 
crystallographically equivalent nucleic acid chains, and their bound ruthenium cations, 
showing how the combination of intercalation by the chloro-dppz ligand and semi-
intercalation by one TAP ligand creates the self-assembling three-dimensional network.  
This Figure shows only the major orientation of the substituted dppz chromophore, 
corresponding to 66% occupancy of this chlorine site. Figure 1d shows a side view of the 
chloro-dppz ligand, from the pyrimidine (T1-C2) side of the cavity. This group faces into 
the solvent channel of the structure, and on this side is not associated with any bound 
water. 
There is a large solvent channel running right through the lattice in the z crystallographic 
direction, and lined by the bases of a compressed major groove. The kinking of about 50 
at the G3-G4 step provides a convenient coordination site for a barium ion. The ion is 
bound to both N7 and O6 positions in the major groove, completing its 8-coordination 
with ordered water, which in turn lines the solvent channel. 
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Figure 2. Stacking interactions of the chlorinated dppz chromophore 
 
Figure 2 shows how the major orientation of the Cl substituent aligns with the basepairs 
of the intercalation cavity. The interpretation is complicated by the flipped out terminal 
adenine base, A10, because it may well be that the Cl orientation is partly determined by 
the presence of flipping out on this side. The stacking pattern is very close to that 
observed in the absence of the chlorine substituent. The influence of Cl substitution is 
seen in two ways – in the increased level of disorder in the structure, and in the presence 
of a water network attached to the dppz pyrazine N atom on the Cl-substituted side of the 
dppz moiety.  The disordered phosphate backbone at A10 has already been mentioned, 
and is associated with two distinct phosphorus positions.  
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Figure 3. Quality of the electron density maps.  
 
More subtle is the effect on the electron density of the two TAP ligands. Although 
chemically identical, they are distinguished by their interactions in this structure. One is 
semi-intercalated (TAP1), while the other is located between the minor grooves of two 
duplexes (TAP2). Figure 3 highlights these differences, showing the almost 
superimposable dppz orientations and resulting highly defined electron density. The 
semi-intercalated TAP1 shows similarly well-behaved density (Figure 3 centre) whereas 
the ‘free’ TAP2 ligand has electron density which clearly shows a degree of smearing-out 
(Figure 3 right). This feature was not observed in the previously reported parent structure 
[4], which is shown for comparison in Figure 3 below, right. We suggest that this might 
be due to the ‘anchoring’ effect of the semi-intercalation by TAP1, which leads to 
unresolved minor differences in the orientations of TAP2 which could be correlated with 
the two orientations of the asymmetrically substituted dppz (Figure 3). 
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The unsubstituted complex ions [Ru(phen)2dppz]
2+
 and [Ru(TAP)2dppz]
2+
 show 
luminescence (specifically ML(phen)CT and ML(TAP)CT) when intercalated into DNA, 
and there has been much literature discussion about the factors required for a long 
luminescent lifetime [1]. The best studied system, [Ru(phen)2dppz]
2+
,  has  
phenanthroline groups as ancillary ligands on the ruthenium, in which case no 
luminescence was observed in aqueous solution [1].  It is widely assumed that the intense 
luminescence when intercalated into DNA is due to the exclusion of water from the 
pyrazine N of the dppz ligand. In the parent complex there are two equivalent N atoms, 
which if intercalated symmetrically [2] would be equally exposed to water. The lifetime 
would then be determined by the local DNA twist angle at the intercalation step. In the 
present structure, the dppz ligand is held at an angle, making the two nitrogens 
inequivalent. The inequivalence is further increased by the asymmetry introduced by Cl 
substitution. In principle there are now two possible dppz orientations and two 
luminescent behaviours.    
Figure 4 compares the water network seen in the presence of Cl substitution and that of 
the unsubstituted dppz. The presence of Cl appears to promote the binding of a partly 
occupied water molecule to the chloro-dppz phenazine N, perhaps because the electronic 
effect of Cl substitution on the pyrazine N makes it a better electron pair donor. 
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Figure 4. Water structure around the dppz ligand.  
 
The chloro monosubstituted dppz derivative prepared as a part of this work is only the 
second structurally characterized asymmetric ruthenium-dppz containing complex. 
Recently the 11-(9-acridinyl)dipyrido[3,2-a:2′,3′-c]phenazine compound was synthesised 
and crystallized as the salt in the absence of DNA [8]. This compound shows a reduced 
DNA binding strength compared to the parent [Ru(phen)2(dppz)]
2+
. However no 
measurements have been made to compare an asymmetric and symmetric version of the 
complex, as this reduced binding could be due to the bulk of the acridinyl group. The 
effect of chloro substitution on the dppz group in relation to its DNA binding properties 
has not yet been studied. Whilst [Ru(bpy)2(dppz-11,12-Cl)]
2+
 has been synthesised and 
structurally characterized, no measurements were made to show its interaction with DNA 
[9]. The related complex [Ru(phen)2(dppz-11,12-Cl)]
2+
 has been the subject of a 
biophysical study, and it was found that the binding to DNA was reduced compared to 
[Ru(phen)2(dppz)]
2+
, with intercalation proposed as the major binding mode for the 
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complex[10]. This would suggest that the effect of chloro substitution is to lower the 
binding constant, but further studies using a range of substituents will be necessary to 
judge the balance between steric and electronic effects in generating the most desirable 
photochemical properties. We have not so far studied the effect of substitution on the 
TAP ligand, but nmr studies using Δ-2,9-dimethyl-1,10-phenanthroline have been used to 
show minor groove intercalation into d(GTCGAC)2 [11], and similar minor groove 
binding for an achiral ruthenium complex with two octanucleotides [12]. 
 
Experimental 
Preparation and characterisation of  11-chlorodipyridophenazene.- 
Phenanthroline-5,6-dione was prepared by a modification of the procedure reported by  
Hiort, Lincoln, and  Norden [13]  1,10-Phenanthroline (5 g,  27.7  mmol) was placed in 
concentrated sulphuric acid (30 mL), followed by sodium bromide (2.5 g), and finally 
concentrated nitric acid (15 mL, 70%). The mixture was refluxed at ca. 120 
o
C  for 1 h, 
after which time the condenser was removed and the majority of the bromine vapour was 
allowed to evaporate. (ca. 30 min)  The cooled mixture was then poured into cooled 
water (400 mL), and neutralised carefully (pH 7).  The product was then heated to 80 
o
C, 
filtered hot, allowed to cool, and extracted with dichloromethane (6 100 mL), and dried 
over magnesium sulphate. The filtered, dried product was found to be pure for synthesis 
by NMR. 
The dione (260 mg,  1.24  mmol) was dissolved in ethanol (8 mL).  4-chloro-ortho-
phenylenediamine (176.4 mg,   1.24 mmol) was dissolved in ethanol (6 mL) and added to 
the dione solution.  A trace of p-toluenesulphonic acid was added. And the mixture 
refluxed at ca. 80 
o
C for 3 h. Approximately half of the solvent was evaporated at ca. 110 
0
C, and the cooled and the crude product filtered off.  After washing with  a small 
quantity of ethanol the product was dried under vacuum, extracted into water:ethanol 1:1 
(5 mL using ultrasound and gentle heating to effect solution), filtered hot, and the residue 
dried under vacuum (78.7 mg).  
1
H NMR, 700 MHz,  (DMSO):   9.51 (m, 2H); 9.22 (m, 
2H); 8.48 (d, 1H, J = 2.1 Hz); 8.42 (d, 1H, J = 9.1 Hz); 8.07 (1H, dd, J = 2.1 Hz, J = 9.1 
Hz); 7.96 (m, 2H). 
13
C NMR, 176 MHz: 153.35, 153.22, 148.73, 148.58, 142.52, 142.29, 
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141.83, 140.99, 136.27, 133.89, 133.81, 132.55, 131.73, 128.37, 127.44, 127.35, 125.30, 
125.28, 118.76) 
Preparation of  11-chlorodipyridophenazenebis(1,4,5,8-tetraazaphenanthrene)- 
ruthenium(II) hexafluorophosphate 
Bis(1,4,5,8-tetraazaphenanthrene)ruthenium(II) dichloride (40.2 mg,  0.075 mmol) and 
11-chlorodipyridophenazene (23.5 mg, 0.075 mmol) were placed in a microwave reaction 
tube (9 mL capacity) together with water:ethanol 1:1 (7 mL).  The vessel was purged 
with dinitrogen for 15 minutes, and then sealed.  The reaction was carried out in the 
microwave reactor (40 min., 140 °C, 150 W) and the vessel allowed to cool. To the 
cooled solution a saturated solution of ammonium hexafluorophosphate was added 
dropwise to precipitate the product. The solution was filtered, and the solid residue was 
washed with water (1), a small quantity of ethanol (1), and finally with a small 
quantity of diethyl ether.  The product was dried under reduced pressure and obtained as 
a dark red solid (76 mg). 
1
H NMR, 700 MHz,  (DMSO):   9.63 (m, 2H); 9.09 (d, 2H); 
9.07 (d, 2H); 8.67 (m, 4H); 8.65 (d, 1H); 8.56 (m, 1H); 8.49 (d, 2H); 8.38 (m, 4H); 8.22 
(d, 1H); 7.94 (m, 2H). 
13
C NMR, 176 MHz: 156.05, 155.92, 150.87,150.70, 150.37, 
150.18, 150.16, 149.71, 145.22, 145.09, 142.71, 142.47, 142.46, 141.23, 140.03, 137.86, 
135.02, 134.98, 134.03, 133.09, 132.91, 131.97, 130.46, 130.37, 128.64, 128.44. (26 of 
the expected 28 signals are resolved.  2 peaks overlap even at 700 MHz). It was 
converted to the chloride salt using Amberlite resin for the crystallisations. 
Crystallization, data collection, structure solution and refinement 
The crystallization was performed, using the sitting drop method, by adding 1µl of 3mM 
rac-[Ru(TAP)2(11-chloro-dppz)]
2+
 to a drop containing 1 µl of 1 mM 
d(TCGGCGCCGA)2, and 6ul of 12mM spermine, 10% 2-methyl-2,4-pentanediol,  40mM 
sodium cacodylate pH 6.3, 80mM NaCl and 20mM BaCl2. This was equilibrated against 
1ml of 35% 2-methyl-2,4-pentanediol. Orange crystals, approximately 150x150x150 µm 
in size and only containing Λ-[Ru(TAP)2(11-Cl-dppz)]
2+
, appeared after 7 days at room 
temperature. 
The 90° of data were collected in 900 frames with a 0.1° oscillation at Diamond Light 
Source on beamline I02 using radiation of wavelength 0.8266 Å at 100 K. The data were 
processed using xia2 [14] using XDS[15] and SCALA [16], in the CCP4 suite [17], to 
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give 18496 unique reflections to 1.02 Å resolution. The structure was solved by molecular 
replacement using Phaser[18] and model 3QRN from the Protein Data Bank, and was 
updated using Coot[19]. The structure was refined using Refmac version 5.6 [20] to give 
a final Rwork of 0.10 and Rfree of 0.11. 5% of reflections were used for the Rfree test. The 
model and experimental data are deposited in the Protein Data Bank with ID 4III. 
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